[The risk and treatment of hyperlipoproteinemias].
The role of lipid disorders in the pathogenesis of coronary heart disease is reviewed. It is also presented the pathophysiology of hyperlipidemias and its current therapeutic policies.
Alzamora
P
P
Departamento de Cardiología y Cirugía Cardiovascular, Facultad de Medicina, Universidad de Navarra, Pamplona.
Alegría
E
E
Iglesias
I
I
D003327:Coronary Disease / Q000097:blood / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D004041:Dietary Fats / Q000008:administration & dosage; D006801:Humans; D006951:Hyperlipoproteinemias / Q000097:blood / Q000150:complications / Q000453:epidemiology* / Q000628:therapy; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D008055:Lipids / Q000097:blood; D008074:Lipoproteins / Q000097:blood; D012307:Risk Factors
D004041:Dietary Fats; D000960:Hypolipidemic Agents; D008055:Lipids; D008074:Lipoproteins
Riesgo y tratamiento de las hiperlipoproteinemias.